Skip to main content
  • Home
  • Library
  • Read
    • Popular
    • Charts
    • Browse
    • Categories
    • Wikis
    • Glossary
  • Request
  • Activity
  • Leaderboard
  • Help
Our Apps
  • DaoSearch
  • Narratorr
Social
  • Discord
  • Patreon
I Can Extract Side Effects
Chapter 238

Generic Drug Factory

2,361 words 8 min read 1 view 4mo ago Source ​
Skip to the end of the chapter
Prev
Next

In a conference room of the agricultural products department at the Sanqing Headquarters.

Huang Qin stood confidently at the front, speaking eloquently.

He and Williams, as key members of the Gene Laboratory, led a research team and joined the collaborative project between the Crop Science Department and Syngenta.

After a lot of hard work, we finally achieved some impressive results.

At this moment, he is giving his colleagues a detailed account of the work progress.

Everyone got along very well during this period, so the atmosphere in the meeting room was quite relaxed.

"Ladies and gentlemen, this insect-resistant corn, after being edited with insect-resistant and high-yield genes, has excellent effects. Its control effect against Fall Armyworm can reach more than 98%, which not only greatly reduces the cost of insect control, but also increases the number of rows and kernels per ear, ultimately increasing the yield by 31%."

"There is also this rice variety, which combines the expression of both insect-resistant and drought-resistant genes, achieving an effectiveness of 95% and increasing yield by 11%. Our next step is to continue to study the genome of this variety and try to add more advantages."

"As everyone knows, the main difference between ordinary Rice and high-quality Rice lies in the content of amylose and amylopectin. This is also the next direction of our research. By regulating the expression of starch genes in rice, we can reduce the amylose content to a limit of 20%, the lower the better, so that the rice will taste better."

"In the past, achieving this quality required very demanding conditions for rice cultivation. In addition to human fertilization, the temperature during the grain-filling stage was also directly related. Only when the average temperature was between 23 and 25 degrees Celsius and the temperature difference between day and night was greater than 10 degrees Celsius could the content of protein and amylose be guaranteed to be at its lowest, thus producing Rice with the best taste."

"However, now we can directly edit the relevant genes and cultivate the best seeds by using Gene Editing tools. Not only do we not need such harsh conditions, but the yield will also increase significantly."

"Rice is the most important food crop in China, and more than 60% of the population relies on Rice as their staple food, so this new seed has unlimited potential."

"Of course, scientific research is a never-ending process. This is just a stage of research results, and we still look forward to continuous progress."

As soon as Huang Qin finished speaking, a round of enthusiastic applause rang out.

As soon as he sat down, Liu Dan, the deputy leader of the Syngenta seed team, went up to him.

Liu Dan said excitedly, "I have seen all your hard work and dedication during this period, and I am truly grateful."

"We will never forget your achievements in reforming China's seed industry. As Team Leader Huang just said, we have already produced three groundbreaking seeds in a short period of time. Now, we will see the results after planting."

"I have received a message from the seed base that the high-yield soybeans have sprouted and broken through the soil, and the seedlings are growing well. Once they mature, the yield should be impressive."

"Three Purities truly lives up to its Three Purities. Our entire company is utterly impressed by your technical prowess. Other research teams need several years to make a breakthrough, but you accomplished all this in just a few weeks. It's truly astonishing."

"I can't believe how earth-shattering the changes will be if such technological power were invested in China's seed industry, and how much economic value it will bring to the entire agriculture sector."

"Take genetically modified corn as an example. It will generate hundreds of billions of yuan in added value every year. Corn is my country's largest grain crop. Last year, my country's corn planting area was 600 million mu. If our genetically modified corn is promoted, it can increase corn yield by 30% per mu and add nearly 500 yuan in value. This number may not seem very high, but multiplied by 600 million, it is 300 billion yuan, which is an astronomical figure."

"In this way, the whole pie will get bigger, and every participant will benefit."

"Generally, the price of Genetically Modified seeds is more than double overseas, but the price increase for our genetically modified seeds is not that high. Therefore, farmers and downstream companies will be the biggest beneficiaries in this value chain."

"Farmers make the lion's share of the profits, and we and our distributors also see some profit growth. This creates a positive cycle, giving us more motivation and capital to invest in research and development, and to continue to expand and strengthen the market."

"There's a saying in the seed industry: whoever controls Genetically Modified controls Fortune. I hope we can join hands and work together to master this source of Fortune."

The meeting room erupted in even more enthusiastic applause.

Everyone's faces were flushed, their eyes shining, and they were thrilled by the future Liu Dan described.

******

Chang City, a medium-sized pharmaceutical company called Divine Land.

Boss Xie Wei sat in his office, staring at the five or six letters on his desk, his brows furrowed and his face gloomy.

At the end of last year, the shadow of price reductions brought about by centralized procurement loomed over pharmaceutical companies as a whole.

Everyone was expecting policy improvements this year, but before the policies were loosened, the upstream industry delivered a new "gift".

He received five or six letters in one day regarding the increase in raw material prices.

These five or six letters included almost all the production materials, such as raw materials, excipients, packaging materials, and chemical raw materials, making this pharmaceutical company in Su Province feel a bit of a chill in the approaching spring.

Not long ago, he had already keenly sensed the signs of price increases in the market, but he did not expect the price increase notice to come so quickly.

The letter indicates that due to increasingly stringent environmental assessments and rising prices of upstream chemical raw materials, pharmaceutical raw material companies have been forced to raise prices.

The price of antibiotic raw materials has risen significantly. Among them, Penicillin G Potassium, an intermediate for cephalosporins and Penicillin, Penem intermediates have all reached their highest values in nearly two years, while Heparin (a raw material for antithrombotic and Anticoagulant Drug) has also increased by nearly 200%.

Divine Land Pharmaceutical previously won the bid with a 'low price' at the centralized procurement negotiation table. Helpless, it had to pass the pressure of price reduction to the upstream, but no raw material pharmaceutical companies accepted the challenge. Instead, they responded with a sharp increase in prices.

Xie Wei almost coughed up a mouthful of blood, feeling a surge of frustration in his heart.

Life is unbearable. On one hand, there's low-price bulk purchasing, and on the other hand, raw material prices are skyrocketing. He can only struggle desperately in the cracks, trying to see how long he can hold on.

The only options are to cut costs and increase revenue, avoid popular pharmaceutical products, and choose products that are unique, small and refined, with relatively high gross margins and a single product with an annual market value of over 100 million, but with only two or three manufacturers.

Of course, Xie Wei knew in his heart that he didn't have the capability to develop original drugs, so he could only make generic drugs. In that case, choosing a product would be quite difficult, with a large investment, a long cycle, and greater uncertainty.

Divine Land survived to this day by relying on one or two varieties of food for 5 or 10 years.

Xie Wei was pulling at his hair, racking his brains for a way to transform the company, when the phone suddenly rang.

"Hey, Mr. Zhao, hello, long time no see. What? Three Purities is looking for outsourced manufacturing and wants to know if I'm interested?"

Xie Wei jolted awake and sat bolt upright. "Yes, I'm extremely interested! When will you come to inspect this place? I'll be waiting for you anytime."

After hanging up the phone, he couldn't contain his excitement. He suddenly stood up and paced back and forth in the office, overwhelmed with excitement.

The fact that Sanqing Group, a major pharmaceutical company in China, is looking for outsourcing manufacturing is like a windfall.

As is well known, the gross profit margin of original drugs is very high, often reaching 80% or 90%, which can be described as extremely profitable.

Although we don't know Three Purities's profit margin, everyone knows that its products sell well both at home and abroad, and its annual output is astonishing.

To ensure quality, Three Purities has always produced all its medicines in its own factory, and has never outsourced even the low-profit generic drugs.

The sudden shift clearly sends a strong signal.

At first, they were just looking for contract manufacturers for generic drugs, but in the future, if they do well, they will definitely be able to contract manufacture original drugs.

Furthermore, if they can establish in-depth cooperation with Three Purities in research and development and transform into a CDMO, it's not impossible for them to soar to new heights.

Pharmaceutical contract manufacturing can be divided into two types: one is pure manufacturing like Foxconn, which belongs to CMO; the other is the model of TSMC, which combines R&D and manufacturing, which belongs to CDMO.

Many large domestic pharmaceutical companies have been manufacturing for global pharmaceutical giants such as Pfizer, Novartis, and Bayer. They have gradually moved from CMO to CDMO and eventually even developed their own original drugs, which has led to their success and soaring stock prices.

Xie Wei had only one thought in his mind at that moment: this was a rare opportunity that he had to seize.

Becoming a contract manufacturer for Three Purities has two advantages: first, it allows them to release excess production capacity; second, it allows them to connect with innovative pharmaceutical companies.

Only in this way can we hope to become a high-end player in the pharmaceutical market.

He is also very clear about his own advantages. Over the years, Divine Land has accumulated excellent production capacity and quality management capabilities, and its cost control is also very strong, earning it an outstanding reputation in the industry.

However, they have virtually no R&D capabilities, so they can only produce generic drugs that are readily available everywhere, with gross profit margins hovering around 30% to 40%.

Although the profit margin offered by Three Purities may not be as high as that of doing it yourself, in the current market situation, having a stable and large number of orders is already a rare achievement. It not only helps them avoid bankruptcy but also allows them to gain a foothold in the market.

Thinking of this, Xie Wei excitedly walked out of the office. He was going to make good preparations to meet the rigorous inspection of the major client.

Three days later, the Three Purities group arrived as scheduled, including several business personnel and two senior executives.

One is Zhao Xiaojie, the purchasing director, and the other is Gu Xian, the generic drug business director.

Xie Wei, like Zhao Xiaojie, was a middle-aged man in his forties, and he was quite surprised to see that Gu Xian was so young.

However, he did not show any abnormality; on the contrary, he became even more attentive.

After welcoming the two into the office and exchanging pleasantries, I finally learned more details about the situation.

"The OEM orders are mainly for overseas clients?" Xie Wei felt a mix of joy and worry.

The concern is that overseas orders have high quality requirements, which are difficult for most pharmaceutical companies to meet. Moreover, from a global perspective, the cost advantage is not significant, and they may not be able to compete with India's generic drug giants.

The good news is that the order volume will definitely be large, and we can win by scale. Even if we operate on a low-profit, high-volume basis, we will still have enough profit.

This puts pharmaceutical companies to the test in terms of management capabilities, with cost and efficiency control being of paramount importance.

Xie Wei had anticipated this and quickly took his guests to inspect the workshop.

Gu Xian was quite satisfied with Divine Land Pharmaceutical. The workshop was very well-organized and clean, and the employees were in good spirits, which showed that the boss had a good management level.

He and Xie Wei also discussed the production process. It was clear that Xie Wei was quite knowledgeable in the technical field, having a technical background rather than being the kind of slick old hand who relied solely on personal connections.

Zhao Xiaojie was quite satisfied with the quote, and Xie Wei was very cooperative.

This time, he was instructed by Wei Kang to outsource the unprofitable generic drug business, so balancing cost and quality became the key consideration.

Both sides were satisfied with each other's terms and quickly reached an agreement.

The next step is trial production. Three batches need to be produced for a six-month stability test. Only if the quality is the same as that of the original Three Purities brand can it be considered officially approved, and then all subsequent generic drug orders will be placed with them.

Three Purities will also send employees to be stationed there to supervise the production process and procedures.

In short, Divine Land has made steady progress toward becoming a major contract manufacturer.

The next day, Three Purities and his group went to another pharmaceutical factory for inspection.

Xie Wei squinted at the letters from the raw material pharmaceutical companies on his desk, and suddenly felt more confident.

"Damn it!" A glint of light flashed in his eyes; he wanted to have a good talk with these opportunistic bastards.

Now that we've found a powerful ally and have a large number of orders in hand, a more favorable price is certainly negotiable.

You should know that this is a great opportunity to enter the raw material supply chain of Sanqing Group.

These raw material pharmaceutical companies must know the benefits of having a powerful backer.

Thinking of this, he chuckled.

The crisis facing Divine Land pharmaceutical companies seems to have been resolved even before it arrived.

End of Chapter
Prev
NovelSummaries
Next

Explore the wiki

Wei Kang
China
Huang Qin

Comments

No comments yet.
AboutStatsAPIChangelogStatusContactPrivacyTermsDMCA
© 2026 RandomTranslator·v3.26·RSS